Goodrich Petroleum Corp. (NYSE:GDP) shares moved up 6.77% in last trading session and ended the day at $0.75. GDP Gross Margin is 79.90% and its has a return on assets of -49.00%. Goodrich Petroleum Corp. (NYSE:GDP) quarterly performance is -21.33%.
Goodrich Petroleum Corp. (NYSE:GDP) announced that it has hired Joseph T. Leary as its Interim Chief Financial Officer. Mr. Leary has 28 years of energy finance and treasury experience and 10 years of banking experience. Mr. Leary has held various executive positions within the energy industry and was formerly the Chief Financial Officer of KCS Energy, Inc. (2003 – 2006), Energy Partners, Ltd. (2007 – 2009) and Tarpon (2011 – 2014).
On 20 October, 3M Company (NYSE:MMM) shares advanced 0.75% and was closed at $149.11. MMM EPS growth in last 5 year was 10.60%. 3M Company (NYSE:MMM) year to date (YTD) performance is -7.48%.
On 13 October, 3M Company (NYSE:MMM) received a contract modification worth $34 million from the Army to provide 28,000 pieces of body armor under the Soldier Protection Systems Vital Torso Protection program for lightweight enhanced small arms protective inserts (ESAPI).
Merck & Co. Inc. (NYSE:MRK) shares fell -1.96% in last trading session and ended the day at $50.39. MRK Gross Margin is 63.00% and its has a return on assets of 9.60%. Merck & Co. Inc. (NYSE:MRK) quarterly performance is -12.57%.
On 7 October, Merck & Co. Inc. (NYSE:MRK) said that, it will make a $US9 million ($A12.49 million) investment in local biotech Bionomics, focusing on the treatment of diseases of the central nervous system and cancer.
Barrick Gold Corporation (NYSE:ABX) caters to the Basic Materials space. It has a net profit margin of -27.70% and weekly performance is 5.76%. On the last day of trading company shares ended up at $7.89. Barrick Gold Corporation (NYSE:ABX) distance from 50-day simple moving average (SMA50) is 12.55%.
Barrick Gold Corporation (NYSE:ABX) announced that, it will release Third Quarter Results on October 28th after market close The Conference Call will be available for replay until November 12th, 2015.
Johnson & Johnson (NYSE:JNJ) shares moved down -0.36% in last trading session and ended the day at $97.59. JNJ Gross Margin is 69.20% and its has a return on assets of 11.20%. Johnson & Johnson (NYSE:JNJ) quarterly performance is -1.84%.
On 9 October, Johnson & Johnson (NYSE:JNJ) has begun clinical trials for an Ebola vaccine in Sierra Leone. The vaccine regimen is part of a new study being conducted in that nation’s Kambia district, where some of the country’s most recent Ebola cases have been reported.
Leave a Reply